GAD Antibodies

Santa Cruz Biotechnology delivers a wide array of GAD Antibodies for research focused on understanding glutamic acid decarboxylase (GAD) in various biological processes. GAD Antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).Glutamic acid decarboxylase is a key enzyme responsible for the synthesis of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system. GAD plays a crucial role in regulating neuronal excitability and maintaining the balance between excitation and inhibition in the brain. Dysregulation of GAD has been implicated in various neurological disorders, including epilepsy, anxiety disorders, and autoimmune conditions. GAD research has revealed significant insights into neurotransmitter regulation and synaptic plasticity. Understanding GAD function and distribution patterns continues to advance knowledge in neuroscience and related fields. Exploring GAD mechanisms helps identify potential therapeutic targets for neurological conditions. Santa Cruz Biotechnology monoclonal antibodies for GAD support researchers worldwide in advancing neuroscience discoveries and developing potential therapeutic strategies.